B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Abbv 744

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Abbv 744, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

apabetalone
4 shared targets
birabresib
3 shared targets
mivebresib
4 shared targets
inobrodib
4 shared targets
methylpyrrolidone
2 shared targets
35
2 shared targets
azd
4 shared targets
withanolide
2 shared targets
ly
4 shared targets
volasertib
2 shared targets
Loading evidence profile...

This evidence profile for Abbv 744 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.